City

Duarte (3)

Houston (1)

New York (1)

Philadelphia (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Withdrawn (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

City of Hope Medical Center (3)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

laboratory biomarker analysis (2)

lenalidomide (2)

brentuximab vedotin (1)

durvalumab (1)

extracorporeal photopheresis (1)

mogamulizumab (1)

quality-of-life assessment (1)

questionnaire administration (1)

Study Documents

Intervention Type

other (3)

biological (2)

drug (2)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

folliculotropic mycosis fungoides

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

Recruiting

Folliculotropic Mycosis Fungoides
+7 more

Durvalumab
+2 more

Duarte, California
+3 more

Jan 12, 2023

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting

Folliculotropic Mycosis Fungoides
+7 more

Extracorporeal Photopheresis
+3 more

Duarte, California

City of Hope Medical Center

Dec 8, 2022

CD30-Positive Neoplastic Cells Present, Folliculotropic Mycosis Fungoides, Recurrent Mycosis Fungoides Trial in Duarte

Withdrawn

CD30-Positive Neoplastic Cells Present
+6 more

Brentuximab Vedotin
+2 more

Duarte, California

City of Hope Medical Center

Apr 26, 2019